Artificial Intelligence: Making Up Our Minds

MACHINES AND INTELLIGENCE A Critique of Arguments Against the Possibility of Artificial Intelligence. Stuart Goldkind. Greenwood Press. Westport, CT, 1987. 138 pp. $29.95. MAN-MADE MINDS The Promise of Artificial Intelligence. M. Mitchell Waidrop. Walker and Company, New York, 1987. 288 pp. $22.95 HB, $14.95 PB. After 30 years, investigators and critics of artificial intelligence (AT) continue to differ in their definitions of the domain and the fundamental claim that AI is or is not possib

Written byDavid King
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A Critique of Arguments Against the Possibility of Artificial Intelligence.
Stuart Goldkind. Greenwood Press.
Westport, CT, 1987. 138 pp. $29.95.

The Promise of Artificial Intelligence.
M. Mitchell Waidrop. Walker and
Company, New York, 1987. 288 pp.
$22.95 HB, $14.95 PB.

After 30 years, investigators and critics of artificial intelligence (AT) continue to differ in their definitions of the domain and the fundamental claim that AI is or is not possible. Academics have a stake in the outcome. So do scientists and engineers who leverage their efforts with computers. More and more, software products are likely to claim additional function and benefit due to AI techniques. Should these products be required to display the message: “Caution: this software is based on a scientific domain that may not be possible”? Two recent publications offer contemporary summaries of this continuing debate. Stuart Goldkind’s monograph Machines and Intelligence examines the arguments surrounding the possibilities ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies